FluidAI Medical (FluidAI) announced the launch of its medical device, the Stream Platform, in Canada and Saudi Arabia.
Through the use of the Stream Platform, surgeons have the potential to make a more accurate and timely diagnosis of postoperative leaks, which can lead to better treatment outcomes and an improved quality of life for their patients. Stream Platform's international debut was made possible through the company's strategic partnerships with Canadian Hospital Specialties Limited (CHS Ltd.) and Gulf Medical Co. Ltd.
Postoperative leaks are a potential complication for patients who have undergone gastrointestinal surgery. Leaks are a significant concern, carrying a high risk of morbidity and mortality for patients, potential short- and long-term consequences, and significant implications for healthcare systems more broadly, including increased length of patient stay and decreased quality of life.
The Stream Platform is a system that use patient-specific data to improve postoperative care. Using sensors and an AI-driven algorithm, this non-invasive device can help drive detection of leaks early on, which can ultimately save hospitals both time and money.
The Stream Platform consists of the Origin Inline Device, which gathers patient data from the surgical site; and the Delta Bedside Monitor, a tablet that utilizes the Stream app to analyze and display the patient data.
